Chrysanthi Sidiropoulou

Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

M. Netea, G. Chatellier, M. Sormani, 2021, The Lancet Rheumatology.

Bloodstream Infections in a COVID-19 Non-ICU Department: Microbial Epidemiology, Resistance Profiles and Comparative Analysis of Risk Factors and Patients’ Outcome

A. Stamati, L. Velentza, O. Zarkotou, 2022, Microorganisms.

Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial

H. Milionis, E. Michelakis, E. Giamarellos‐Bourboulis, 2021, Infectious Diseases and Therapy.

Oral clarithromycin in COVID-19 of moderate severity: the ACHIEVE open-label trial using concurrent matched comparators

K. Syrigos, H. Milionis, E. Michelakis, 2020, medRxiv.

Real life treatment experience and outcome of consecutively hospitalised patients with SARS-CoV-2 pneumonia by Omicron-1 vs Delta variants

N. Pantazis, A. Stamati, K. Zoi, 2023, Infectious diseases.